Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.0650
+0.0150 (30.00%)
At close: Mar 20, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 4.4 million as of March 20, 2026. Its market cap has decreased by -69.22% in one year.
Market Cap
4.40M
Enterprise Value
5.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has decreased from 5.25M to 4.40M, a decrease of -16.20%. That is a compound annual growth rate of -4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 4.40M | -56.67% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Restart Life Sciences | 6.22M |
| Aptose Biosciences | 5.67M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| COSCIENS Biopharma | 4.78M |
| XORTX Therapeutics | 4.46M |
| MindBio Therapeutics | 4.27M |